Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.

Montessuit, Christophe

Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture. [electronic resource] - Endocrinology Mar 2008 - 1064-74 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0013-7227

10.1210/en.2007-0656 doi


AMP-Activated Protein Kinase Kinases
Alitretinoin
Animals
Cells, Cultured
Cytoskeleton--drug effects
Glucose--metabolism
Glucose Transporter Type 4--metabolism
Insulin--physiology
Insulin Resistance--physiology
Male
Microtubules--drug effects
Myocytes, Cardiac--drug effects
PPAR gamma--agonists
Phenoxyacetates--pharmacology
Protein Kinases--pharmacology
Pyrimidines--pharmacology
Rats
Rats, Sprague-Dawley
Retinoid X Receptors--agonists
Signal Transduction--drug effects
Thiazolidinediones--pharmacology
Tretinoin--pharmacology